IMPROVEMENT OF REFRACTORY EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS WITH MEPOLIZUMAB INITIATED FOR SEVERE ATOPIC ASTHMA

被引:0
作者
Love, M.
Gierer, S.
Maz, M.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P171
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [31] The Role Of Mepolizumab In Atopic And Non-Atopic Patients With Refractory Eosinophilic Asthma
    Ortega, H. G.
    Chupp, G.
    Bardin, P.
    Bourdin, A.
    Hartley, B.
    Humbert, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] Characteristics of Severe Asthma Clinic Patients With Eosinophilic Granulomatosis With Polyangiitis
    Puan, Youxin
    Ong, Kheng Yong
    Tiew, Pei Yee
    Chen, Gabriel Xu Wen
    Teo, Neville Wei Yang
    Low, Andrea Hsiu Ling
    Wechsler, Michael E.
    Koh, Mariko Siyue
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02) : 361 - 368.e2
  • [33] Evaluation of mepolizumab (MPZ) treatment in Eosinophilic Granulomatosis with Polyangiitis (EGPA) patients in an asthma clinic
    Lopez, Laura Castellanos
    Serrano, Carolina Cisneros
    Marcos, Maria Celeste
    Garcia, Marta Solis
    Hernandez, Ana Sofia Martin
    Menendez, Mateo Hevia
    Garcia, Ana Arcos
    Pelaez-Laderas, Adrian
    Moreno, Carlos Melero
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [34] Mepolizumab for the Treatment of Eosinophilic Granulomatosis With Polyangiitis: Our Experience
    Diaz-Campos, R. M.
    Prudencio-Ribera, V. C.
    Garcia-Moguel, I
    Fernandez-Rodriguez, C.
    Corral-Blanco, M.
    Jarrin-Estupinan, M. E.
    Melero-Moreno, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (05) : 384 - 385
  • [35] Low Dose of Mepolizumab in Treatment of Eosinophilic Granulomatosis with Polyangiitis
    Maia, A. P.
    San Martin, S. R.
    Erazo, A. C. E.
    Toledo, A. P.
    Oliveira, E. P.
    Assuncao, G. L.
    Barbas, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab
    Bourdin, Arnaud
    Wechsler, Michael E.
    Jackson, David J.
    Siddiqui, Salman
    Baudy, Peter
    Menzies-Gow, Andrew
    Necander, Sofia
    Shavit, Anat
    Walton, Claire
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [37] Efficacy of Increasing the Dose of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis
    Pallotti, Federica
    Bonniaud, Philippe
    Smets, Perrine
    Habib, Stephanie
    Perier, Amandine
    Deroux, Alban
    Mankikian, Julie
    Neel, Antoine
    Rousselin, Clementine
    Seror, Raphaele
    Taille, Camille
    Crickx, Etienne
    La Croix, Candice
    Blanche, Philippe
    Guillevin, Loic
    Puechal, Xavier
    Terrier, Benjamin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3259 - 3261
  • [38] Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Pradhan, Ravi Ranjan
    Nepal, Gaurav
    Mandal, Shobha
    PULMONARY MEDICINE, 2019, 2019
  • [39] MEPOLIZUMAB INDUCTION THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA)
    Goldstein, M.
    Vadaketh, K.
    Dvorin, D.
    Belecanech, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
  • [40] Asthma remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following treatment with benralizumab or mepolizumab
    Bourdin, A.
    Wechsler, M. E.
    Jackson, D. J.
    Siddiqu, S.
    Baudy, P.
    Menzies-Gow, A.
    Shavit, A.
    Necander, S.
    Walton, C.
    ALLERGOLOGIE, 2024, 47 (09)